← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2019Last known activity
Dec 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05125081Overall official - principal investigatorPhase 2Dec 1, 2021
- NCT05035979Study chairPhase 3Dec 1, 2021
- NCT03823248CollaboratorPhase 1/Phase 2Mar 1, 2019
Details
- Last known activity
- Dec 1, 2021